
Doctor-prescribed GLP-1 receptor agonist care for eligible adults, with provider review, transparent pricing, and LeanDose support.
Compounded Semaglutide is a GLP-1 medication option that may be considered for eligible patients after clinical review. Compounded medications are not FDA-approved, and a licensed provider must decide whether treatment is appropriate.
GLP-1 pathways can help eligible patients reduce appetite and food noise.
LeanDose uses a clinical intake and provider review before prescribing.
Compounded Semaglutide is listed at $197/month in the LeanDose offer.
| Medication | LeanDose price | Best-fit positioning |
|---|---|---|
| Compounded Semaglutide | $197/mo | Entry GLP-1 option for eligible adults seeking appetite and weight-management support. |
| Compounded Tirz GLP-1/GIP | $385/mo | Dual-action option for eligible adults who may benefit from GLP-1/GIP support. |

Take the private eligibility quiz before provider review.
Start Eligibility Quiz